Loading...
Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment
Despite the recent substantial improvement of clinical outcome in mantle cell lymphoma (MCL), resistance to immunochemotherapy and common relapses are challenges for long-term tumor control. The assessment of minimal residual disease (MRD) by real-time quantitative polymerase chain reaction has emer...
Saved in:
| Published in: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Hematology
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142459/ https://ncbi.nlm.nih.gov/pubmed/27913513 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|